MX2010005225A - Phenylpyrazole derivatives. - Google Patents
Phenylpyrazole derivatives.Info
- Publication number
- MX2010005225A MX2010005225A MX2010005225A MX2010005225A MX2010005225A MX 2010005225 A MX2010005225 A MX 2010005225A MX 2010005225 A MX2010005225 A MX 2010005225A MX 2010005225 A MX2010005225 A MX 2010005225A MX 2010005225 A MX2010005225 A MX 2010005225A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- disorder
- halogeno
- general formula
- sleep
- Prior art date
Links
- 150000008048 phenylpyrazoles Chemical class 0.000 title abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 abstract 1
- 208000017164 Chronobiology disease Diseases 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- 208000030814 Eating disease Diseases 0.000 abstract 1
- 208000019454 Feeding and Eating disease Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 235000014632 disordered eating Nutrition 0.000 abstract 1
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 201000003631 narcolepsy Diseases 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 201000002859 sleep apnea Diseases 0.000 abstract 1
- 208000019116 sleep disease Diseases 0.000 abstract 1
- 208000020685 sleep-wake disease Diseases 0.000 abstract 1
- 229940126585 therapeutic drug Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
The invention provides preventive or therapeutic drugs for dementia, Alzheimer disease, attention deficit/hyperactivity disorder, schizophrenia, eating disorder, obesity, diabetes, hyperlipemia, sleep disorder, narcolepsy, sleep-apnea syndrome, circadian rhythm disorder, depression, allergic rhinitis, and other diseases. Phenylpyrazole derivatives represented by the general formula (1) or pharmaceutically acceptable salts thereof, wherein R1 and R2 may be the same or different and are each C1-6 alkyl or C3-8 cycloalkyl, or R1 and R2 together with the nitrogen atom adjacent to both may form a 4- to 7-membered saturated heterocycle (which may be substituted with halogeno and C1-6 alkyl); n is an integer of 0 to 2; T is hydrogen, halogeno, or C1-6 alkyl; and R is a group represented by the general formula (I) or the like.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007294040 | 2007-11-13 | ||
| JP2008153736 | 2008-06-12 | ||
| PCT/JP2008/070712 WO2009063953A1 (en) | 2007-11-13 | 2008-11-13 | Phenylpyrazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010005225A true MX2010005225A (en) | 2010-05-27 |
Family
ID=40638800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010005225A MX2010005225A (en) | 2007-11-13 | 2008-11-13 | Phenylpyrazole derivatives. |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US7888354B2 (en) |
| EP (1) | EP2221298B1 (en) |
| JP (2) | JP4543344B2 (en) |
| KR (1) | KR101571176B1 (en) |
| CN (1) | CN101855211B (en) |
| AU (1) | AU2008321823B2 (en) |
| BR (1) | BRPI0820432B8 (en) |
| CA (1) | CA2705502C (en) |
| CY (1) | CY1114877T1 (en) |
| DK (1) | DK2221298T3 (en) |
| ES (1) | ES2436146T3 (en) |
| HK (1) | HK1145834A1 (en) |
| HR (1) | HRP20131060T1 (en) |
| IL (2) | IL205509A (en) |
| MX (1) | MX2010005225A (en) |
| MY (1) | MY173546A (en) |
| NZ (1) | NZ585661A (en) |
| PL (1) | PL2221298T3 (en) |
| PT (1) | PT2221298E (en) |
| RS (1) | RS53125B (en) |
| RU (1) | RU2480456C2 (en) |
| SI (1) | SI2221298T1 (en) |
| WO (1) | WO2009063953A1 (en) |
| ZA (1) | ZA201003111B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100113776A1 (en) * | 2006-12-14 | 2010-05-06 | Taisho Pharmaceutical Co.,Ltd. | Pyrazole derivative |
| CA2705502C (en) * | 2007-11-13 | 2016-01-26 | Taisho Pharmaceutical Co., Ltd. | Phenylpyrazole derivatives |
| JP5740838B2 (en) * | 2009-05-12 | 2015-07-01 | 大正製薬株式会社 | Phenylpyrazole derivatives |
| EP2789608A4 (en) * | 2011-12-08 | 2015-07-01 | Taisho Pharmaceutical Co Ltd | Phenylpyrrole derivative |
| JPWO2013100054A1 (en) * | 2011-12-27 | 2015-05-11 | 大正製薬株式会社 | Phenyltriazole derivatives |
| WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
| PT2928474T (en) * | 2012-12-07 | 2019-01-30 | Chemocentryx Inc | Diazole lactams |
| KR20150108384A (en) * | 2013-01-17 | 2015-09-25 | 에프. 호프만-라 로슈 아게 | Oxytocin receptor agonists for the treatment of cns diseases |
| ES2864148T3 (en) | 2016-04-07 | 2021-10-13 | Chemocentryx Inc | Reduction of tumor burden by administration of CCR1 antagonists in combination with PD-1 inhibitors or PD-L1 inhibitors |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL104311A (en) * | 1992-02-05 | 1997-07-13 | Fujisawa Pharmaceutical Co | Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
| PT1311482E (en) | 2000-08-08 | 2007-04-30 | Ortho Mcneil Pharm Inc | Non-imidazole aryloxypiperidines as h3 receptor ligands |
| US6316475B1 (en) * | 2000-11-17 | 2001-11-13 | Abbott Laboratories | Aminoalkoxybiphenylcarboxamides as histamine-3 receptor ligands and their therapeutic applications |
| CA2440238C (en) * | 2001-03-16 | 2011-09-13 | Abbott Laboratories | Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| EP1642898B1 (en) * | 2003-06-27 | 2013-03-27 | Msd K.K. | Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| JP2007531753A (en) | 2004-03-31 | 2007-11-08 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Non-imidazole heterocyclic compounds |
| GB0408083D0 (en) | 2004-04-08 | 2004-05-12 | Glaxo Group Ltd | Novel compounds |
| FR2870846B1 (en) | 2004-05-25 | 2006-08-04 | Sanofi Synthelabo | TETRAHYDROISOQUINOLYLSULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
| SE0401971D0 (en) | 2004-08-02 | 2004-08-02 | Astrazeneca Ab | Piperidne derivatives |
| WO2006023462A1 (en) | 2004-08-23 | 2006-03-02 | Eli Lilly And Company | Histamine h3 receptor agents, preparation and therapeutic uses |
| ATE517882T1 (en) | 2004-10-19 | 2011-08-15 | Hoffmann La Roche | QUINOLINE DERIVATIVES |
| WO2006046131A1 (en) | 2004-10-29 | 2006-05-04 | Pfizer Products Inc. | Tetralin histamine-3 receptor antagonists |
| US8158652B2 (en) * | 2004-12-01 | 2012-04-17 | Msd K.K. | Substituted pyridone derivative |
| RU2007125648A (en) | 2004-12-07 | 2009-01-20 | Глэксо Груп Лимитед (GB) | INDENIL DERIVATIVES AND THEIR APPLICATION FOR TREATMENT OF NEUROLOGICAL DISORDERS |
| JP2008534542A (en) * | 2005-03-31 | 2008-08-28 | ユセベ ファルマ ソシエテ アノニム | Compounds containing an oxazole moiety or a thiazole moiety, processes for their preparation and their use |
| BRPI0608653A2 (en) | 2005-04-01 | 2010-11-30 | Lilly Co Eli | compound or a pharmaceutically acceptable salt thereof, pharmaceutical composition, and use of a compound or salt thereof |
| DE102005033448A1 (en) * | 2005-07-18 | 2007-01-25 | Josef Gail | Compressed gas cylinder rotor motor |
| GB0514811D0 (en) * | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
| GB0514812D0 (en) * | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
| EP1988777B1 (en) | 2006-02-09 | 2011-09-21 | Athersys, Inc. | Pyrazoles for the treatment of obesity and other cns disorders |
| US20100113776A1 (en) | 2006-12-14 | 2010-05-06 | Taisho Pharmaceutical Co.,Ltd. | Pyrazole derivative |
| CN101711232A (en) * | 2007-04-12 | 2010-05-19 | Dsm精细化学奥地利Nfg两合公司 | Neighbour-chloromethyl phenyl glyoxylic ester, (E)-2-(2-the chloromethyl phenyl)-improvement preparation method of 2-alcoxyl imido grpup acetic ester and the new intermediate that is used for these preparation methods |
| CA2705502C (en) * | 2007-11-13 | 2016-01-26 | Taisho Pharmaceutical Co., Ltd. | Phenylpyrazole derivatives |
-
2008
- 2008-11-13 CA CA2705502A patent/CA2705502C/en active Active
- 2008-11-13 MX MX2010005225A patent/MX2010005225A/en active IP Right Grant
- 2008-11-13 DK DK08849725.0T patent/DK2221298T3/en active
- 2008-11-13 US US12/741,754 patent/US7888354B2/en active Active
- 2008-11-13 WO PCT/JP2008/070712 patent/WO2009063953A1/en active Application Filing
- 2008-11-13 SI SI200831096T patent/SI2221298T1/en unknown
- 2008-11-13 CN CN200880115707XA patent/CN101855211B/en active Active
- 2008-11-13 MY MYPI2010002187A patent/MY173546A/en unknown
- 2008-11-13 JP JP2009541174A patent/JP4543344B2/en active Active
- 2008-11-13 BR BRPI0820432A patent/BRPI0820432B8/en active IP Right Grant
- 2008-11-13 PT PT88497250T patent/PT2221298E/en unknown
- 2008-11-13 EP EP08849725.0A patent/EP2221298B1/en active Active
- 2008-11-13 ES ES08849725T patent/ES2436146T3/en active Active
- 2008-11-13 KR KR1020107009179A patent/KR101571176B1/en active IP Right Grant
- 2008-11-13 RS RS20130586A patent/RS53125B/en unknown
- 2008-11-13 PL PL08849725T patent/PL2221298T3/en unknown
- 2008-11-13 RU RU2010123924/04A patent/RU2480456C2/en active
- 2008-11-13 AU AU2008321823A patent/AU2008321823B2/en active Active
- 2008-11-13 NZ NZ585661A patent/NZ585661A/en unknown
-
2010
- 2010-02-05 JP JP2010024303A patent/JP5375639B2/en not_active Expired - Fee Related
- 2010-05-03 IL IL205509A patent/IL205509A/en active IP Right Grant
- 2010-05-04 ZA ZA2010/03111A patent/ZA201003111B/en unknown
- 2010-11-22 US US12/951,964 patent/US8183387B2/en active Active
- 2010-11-22 US US12/951,978 patent/US8193176B2/en active Active
- 2010-12-29 HK HK10112206.3A patent/HK1145834A1/en unknown
-
2013
- 2013-11-07 HR HRP20131060AT patent/HRP20131060T1/en unknown
-
2014
- 2014-01-09 CY CY20141100018T patent/CY1114877T1/en unknown
- 2014-12-04 IL IL236083A patent/IL236083A/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010005225A (en) | Phenylpyrazole derivatives. | |
| NZ617334A (en) | Cyclopropyl amine derivatives | |
| NO20083356L (en) | Use of 4-imidazole derivatives for CNS diseases | |
| ATE556050T1 (en) | INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE-1 ENZYME | |
| MX2011008336A (en) | Dihydroquinolinone derivatives. | |
| NO20083114L (en) | Polycyclic indazole derivatives which are ERK inhibitors | |
| MX2012012952A (en) | 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds. | |
| WO2007057790A3 (en) | Substituted bicyclic pyrimidone derivatives | |
| NO343929B3 (en) | 1- [2- (2,4-dimethylphenylsulfanyl-phenyl] -piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5HT1A activity for the treatment of cognitive pain | |
| UA98951C2 (en) | 2-aminooxazolines and medicament comprising thereof | |
| MX2010008363A (en) | Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of gsk3-beta. | |
| BR112012027640A2 (en) | compound, pharmaceutical composition, use of a compound, and methods of preparing a pharmaceutical composition, inhibiting the function of 11betahydroxysteroid dehydrogenase type 1 and treating or preventing a disorder | |
| MX2011011489A (en) | Isoxazole-pyridine derivatives. | |
| NO20083058L (en) | Cyclohexylsulfonamide derivatives with H3 receptor activity | |
| NO20091793L (en) | 2-pyridinecarboxamide derivative with GK activating effect | |
| NO20071137L (en) | New piperidine derivatives for the treatment of depression | |
| CA2702933A1 (en) | Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof | |
| NO20082096L (en) | Azaindole-2-karboksamidderivativer | |
| MX2011011273A (en) | Isoxazole-pyrazole derivatives. | |
| MX2012002528A (en) | Therapeutic agent for mood disorders. | |
| CY1117790T1 (en) | Suspension 11-Beta-Hydroxysteroid Inhibitor Compounds 1 | |
| PH12014501293A1 (en) | Phenylpyrrole derivative | |
| MX2016013412A (en) | Morpholin-pyridine derivatives. | |
| TW200700390A (en) | Metabolites for nk-1 antagonists for emesis | |
| BRPI0811220A2 (en) | THERAPEUTIC COMPOUNDS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |